Figure 3.
The effect of pancracine on the proliferation (A) and viability (B) of MOLT-4 and A549 cells. Changes in the proliferation and viability following pancracine treatment were monitored by the Trypan blue exclusion test at 24 and 48 h in MOLT-4 cells and at 24, 48, and 72 h in A549 cells. Results are shown as the mean ± SD from three experiments. * Significantly different to the control (p ≤ 0.05). Cells treated with 0.25-µM doxorubicin were used as a positive control.